In conclusion, this study demonstrates that circSCAP is upregulated in NSCLC cells and facilitates NSCLC progression by sponging miR-7 and upregulating SMAD2, providing a new perspective for early diagnosis and treatment of NSCLC. This evidence concerns the gene SMAD2 and non-small cell lung carcinoma.